ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,310, issued on July 28, was assigned to Shanghaitech University (Shanghai).

"ASIC1 channel antagonist antibody" was invented by Guang Yang (Shanghai) and Min Qiang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology relates generally to compositions and methods of preventing or treating ischemic stroke. The present technology also relates to administering the anti-ASIC1a antibodies in effective amounts to treat a subject suffering from, or predisposed to, ischemic stroke."

The patent was filed on July 23, 2019, under Application No. 17/628,869.

*For further information, including images, charts and tables, please visit:...